Friday, April 28, 2017 4:24:20 PM
Do you think these companies want Stem Cell Research to succeed if "Cost savings" to the health industry? Probably not. Yes, I suppose IF approved THEN they would have interest due to basically ethical reasons, but bottom line is if cheaper, then less money for these companies to make.
Continual drugs vs. One-time procedure? Actually I'm not even sure if it would just be a "one-time" deal, but if repaired, guess it may be? I'm sure every person may react a bit different to the therapy?
C'mon RMAT!!!!
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM